Tseng KC - Search Results

1

Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan.

Liu CH, Peng CY, Liu CJ, Chen CY, Lo CC, Tseng KC, Su PY, Kao WY, Tsai MC, Tung HD, Cheng HT, Lee FJ, Huang CS, Huang KJ, Shih YL, Yang SS, Wu JH, Lai HC, Fang YJ, Chen PY, Hwang JJ, Tseng CW, Su WW, Chang CC, Lee PL, Chen JJ, Chang CY, Hsieh TY, Chang CH, Huang YJ, Kao JH. Liu CH, et al. Among authors: tseng kc, tseng cw. Hepatol Int. 2023 Apr;17(2):291-302. doi: 10.1007/s12072-022-10475-9. Epub 2023 Jan 26. Hepatol Int. 2023. PMID: 36701081

2

Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.

Wu IC, Chow NH, Cheng PN, Liu WC, Young KC, Chang WL, Chen CY, Tseng KC, Chang TT. Wu IC, et al. Among authors: tseng kc. J Med Virol. 2007 Jun;79(6):663-9. doi: 10.1002/jmv.20822. J Med Virol. 2007. PMID: 17457902

3

Low dose erythropoietin-beta improves anemia and maintains ribavirin dose in chronic hepatitis C patients receiving combination therapy with ribavirin plus pegylated interferon Alfa-2b.

Tseng KC, Chen LH, Chen CY, Chang TT, Chou AL, Wu IC, Cheng PN. Tseng KC, et al. Hepatol Res. 2009 Jun;39(6):539-45. doi: 10.1111/j.1872-034X.2009.00489.x. Epub 2009 Feb 25. Hepatol Res. 2009. PMID: 19254345

4

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir.

Wang CC, Tseng KC, Peng CY, Hsieh TY, Lin CL, Su TH, Tseng TC, Hsu CS, Lin HH, Kao JH. Wang CC, et al. Among authors: tseng kc, tseng tc. J Gastroenterol Hepatol. 2013 Jan;28(1):46-50. doi: 10.1111/j.1440-1746.2012.07269.x. J Gastroenterol Hepatol. 2013. PMID: 22989322

5

A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse.

Lee CM, Chen CY, Chien RN, Tseng KC, Peng CY, Tung SY, Fang YJ, Huang YH, Lu SN, Hung CH, Tsai TJ, Fang CC, Hsu CW, Yeh CT. Lee CM, et al. Among authors: tseng kc. J Interferon Cytokine Res. 2014 Mar;34(3):187-94. doi: 10.1089/jir.2013.0074. Epub 2013 Nov 15. J Interferon Cytokine Res. 2014. PMID: 24237300 Free PMC article. Clinical Trial.

6

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.

Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Peng CY, et al. Among authors: tseng kc, tseng tc. J Formos Med Assoc. 2015 Apr;114(4):308-13. doi: 10.1016/j.jfma.2013.10.023. Epub 2013 Dec 5. J Formos Med Assoc. 2015. PMID: 24315616 Free article.

7

Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled study.

Tseng KC, Chen CY, Tsai HW, Chang TT, Chuang WL, Hsu PI, Liu WC, Cheng PN. Tseng KC, et al. Antivir Ther. 2014;19(8):755-64. doi: 10.3851/IMP2754. Epub 2014 Feb 28. Antivir Ther. 2014. PMID: 24583931 Clinical Trial.

8

Peginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic response.

Tseng CW, Chen CY, Chang TT, Tzeng SJ, Hsieh YH, Hung TH, Lee CC, Wu SF, Tseng KC. Tseng CW, et al. Among authors: tseng kc. PLoS One. 2014 Jun 17;9(6):e100207. doi: 10.1371/journal.pone.0100207. eCollection 2014. PLoS One. 2014. PMID: 24937007 Free PMC article.

9

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.

Yang CC, Tsai WL, Su WW, Huang CF, Cheng PN, Lo CC, Tseng KC, Mo LR, Wang CH, Hsu SJ, Lai HC, Su CW, Liu CJ, Peng CY, Yu ML. Yang CC, et al. Among authors: tseng kc. PLoS One. 2015 Sep 14;10(9):e0137852. doi: 10.1371/journal.pone.0137852. eCollection 2015. PLoS One. 2015. PMID: 26368130 Free PMC article.

10

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan.

Wang CC, Lin CL, Hsieh TY, Tseng KC, Peng CY, Su TH, Yang SS, Hsu YC, Chen TM, Kao JH. Wang CC, et al. Among authors: tseng kc. Hepatol Int. 2016 Mar;10(2):294-301. doi: 10.1007/s12072-015-9662-9. Epub 2015 Sep 23. Hepatol Int. 2016. PMID: 26399763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page